Journal of Cancer Education

, Volume 29, Issue 2, pp 247–251

Promoting Gynecologic Cancer Awareness at a Critical Juncture—Where Women and Providers Meet

  • Crystale Purvis Cooper
  • Cynthia A. Gelb
  • Juan Rodriguez
  • Nikki A. Hawkins


Given the absence of effective population-based screening tests for ovarian, uterine, vaginal, and vulvar cancers, early detection can depend on women and health care providers recognizing the potential significance of symptoms. In 2008, the Centers for Disease Control and Prevention’s (CDC) Inside Knowledge campaign began distributing consumer education materials promoting awareness of gynecologic cancer symptoms. We investigated providers’ in-office use of CDC gynecologic cancer materials and their recognition of the symptoms highlighted in the materials. We analyzed data from a national 2012 survey of US primary care physicians, nurse practitioners, and gynecologists (N = 1,380). Less than a quarter of providers (19.4 %) reported using CDC gynecologic cancer education materials in their offices. The provider characteristics associated with the use of CDC materials were not consistent across specialties. However, recognition of symptoms associated with gynecologic cancers was consistently higher among providers who reported using CDC materials. The possibility that providers were educated about gynecologic cancer symptoms through the dissemination of materials intended for their patients is intriguing and warrants further investigation. Distributing consumer education materials in health care provider offices remains a priority for the Inside Knowledge campaign, as the setting where women and health care providers interact is one of the most crucial venues to promote awareness of gynecologic cancer symptoms.


Primary care Health promotion Prevention Patient education Gynecologic cancer 


  1. 1.
    Cancer Education and Awareness Act, HR §1245 (2005)Google Scholar
  2. 2.
    Su Z, Graybill WS, Zhu Y (2013) Detection and monitoring of ovarian cancer. Clin Chim Acta 415:341–345CrossRefPubMedGoogle Scholar
  3. 3.
    Zanotti KM, Kennedy AW (1999) Screening for gynecologic cancer. Med Clin N Am 83:1467–1487CrossRefPubMedGoogle Scholar
  4. 4.
    Lockwood-Rayermann S, Donovan HS, Rambo D, Kuo CW (2009) Women’s awareness of ovarian cancer risks and symptoms. Am J Nurs 109:36–45CrossRefPubMedGoogle Scholar
  5. 5.
    Koldjeski D, Kirkpatrick MK, Everett L, Brown S, Swanson M (2004) Health seeking related to ovarian cancer. Cancer Nurs 27:370–378CrossRefPubMedGoogle Scholar
  6. 6.
    Ryerson AB, Eheman C, Burton J, McCall N, Blackman D, Subramanian S, Richardson LC (2007) Symptoms, diagnoses, and time to key diagnostic procedures among older US women with ovarian cancer. Obstet Gynecol 109:1053–1061CrossRefPubMedGoogle Scholar
  7. 7.
    Rim SH, Polonec L, Stewart SL, Gelb CA (2011) A national initiative for women and health care providers: CDC’s Inside Knowledge: Get the Facts About Gynecologic Cancer campaign. J Women’s Health (Larchmt) 20:1579–1585.
  8. 8.
    Cooper CP, Polonec L, Stewart SL, Gelb CA (2013) Gynaecologic cancer symptom awareness, concern and care seeking among US women: a multi-site qualitative study. Fam Pract 30:96–104PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Hawkins NA, Cooper CP, Saraiya M, Gelb CA, Polonec L (2011) Why the Pap test? Awareness and use of the Pap test among women in the United States. J Women’s Health (Larchmt) 20:511–515CrossRefGoogle Scholar
  10. 10.
    Trivers KF, Rodriguez JL, Hawkins NA, Cooper CP, Polonec L, Gelb CA (2011) Intention to seek care for symptoms associated with gynecologic cancers, HealthStyles survey, 2008. Prev Chronic Dis 8:A144PubMedCentralPubMedGoogle Scholar
  11. 11.
    Cooper CP, Polonec L, Gelb CA (2011) Women’s knowledge and awareness of gynecologic cancer: a multisite qualitative study in the United States. J Women’s Health (Larchmt) 20:517–524CrossRefGoogle Scholar
  12. 12.
    Stormo AR, Cooper CP, Hawkins NA, Saraiya M (2012) Physician characteristics and beliefs associated with use of pelvic examinations in asymptomatic women. Prev Med 54:415–421CrossRefPubMedGoogle Scholar
  13. 13.
    Saraiya M, Rosser JI, Cooper CP (2012) Cancers that US physicians believe the HPV vaccine prevents: findings from a physician survey, 2009. J Women’s Health (Larchmt) 21:111–117CrossRefGoogle Scholar
  14. 14.
    Stormo AR, Hawkins NA, Cooper CP, Saraiya M (2011) The pelvic examination as a screening tool: practices of US physicians. Arch Intern Med 171:2053–2054CrossRefPubMedGoogle Scholar
  15. 15.
    Cumming RG (1990) Is probability sampling always better? A comparison of results from a quota and a probability sample survey. Community Health Stud 14:132–137CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York (outside the USA) 2013

Authors and Affiliations

  • Crystale Purvis Cooper
    • 1
  • Cynthia A. Gelb
    • 2
    • 3
  • Juan Rodriguez
    • 2
  • Nikki A. Hawkins
    • 2
  1. 1.Soltera Center for Cancer Prevention and ControlTucsonUSA
  2. 2.Division of Cancer Prevention and ControlNational Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and PreventionAtlantaUSA
  3. 3.Division of Cancer Prevention and ControlCenters for Disease Control and PreventionChambleeUSA

Personalised recommendations